Berthold Hackl, MsC, MBA
Berthold Hackl is the founder and principal of Sorrento Investment GmbH, a life sciences investment and advisory in the Frankfurt metropolitan region, Germany. He has extensive experience and recognition as an executive, advisor, and board member in the life sciences, including biopharma, diagnostics, medtech, and VC investments. He works extensively in Germany, France and Switzerland, with meaningful reach as well into other European countries.
As General Manager Europe for Eurofins he grew the company’s platform in biopharma and medtech both by successful M&A and organic growth initiatives. As CEO of invendo medical, a pioneer in the development of single-use gastrointestinal endoscopy products, he shepherded the company from early development to FDA clearance until the generation of first revenues. Invendo was acquired by AMBU in 2017.